Changes in the metabolic profiles of the serum and putamen in Parkinson’s disease patients – In vitro and in vivo NMR spectroscopy studies

Hippocampal Metabolite Profiles in Two Rat Models of Autism: NMR-Based Metabolomics Studies

(2020) B. Toczylowska et al.   MOLECULAR NEUROBIOLOGY

Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease

(2019) Yaping Shao et al.   Molecular Neurodegeneration

The Role of Lipids in Parkinson’s Disease

(2019) Helena Xicoy et al.   Cells

Altered Cerebrospinal Fluid Concentrations of Hydrophobic and Hydrophilic Compounds in Early Stages of Multiple Sclerosis—Metabolic Profile Analyses

(2019) A. Podlecka-Piętowska et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

NMR metabolomics: A look ahead

(2019) David S. Wishart   JOURNAL OF MAGNETIC RESONANCE

Metabolomics for Investigating Physiological and Pathophysiological Processes

(2019) David S. Wishart   PHYSIOLOGICAL REVIEWS

High Concentration of Ketone Body β-Hydroxybutyrate Modifies Synaptic Vesicle Cycle and Depolarizes Plasma Membrane of Rat Brain Synaptosomes

(2019) Polina P. Voronina et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Lipophilic antioxidants in neurodegenerative diseases

(2018) Kuo-Hsuan Chang et al.   CLINICA CHIMICA ACTA

Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling

(2018) Huiyuan Zhao et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease

(2018) Kuo-Hsuan Chang et al.   MOLECULAR NEUROBIOLOGY

Neurotransmitters in the mediation of cerebral ischemic injury

(2018) Diana Mayor et al.   NEUROPHARMACOLOGY

Confirmation of brain death using optical methods based on tracking of an optical contrast agent: assessment of diagnostic feasibility

(2018) Wojciech Weigl et al.   Scientific Reports

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease

(2018) Daniel Stoessel et al.   Frontiers in Aging Neuroscience

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease

(2018) Desiree Willkommen et al.   PLoS One

Glutamate, Glutamine and GABA Levels in Rat Brain Measured Using MRS, HPLC and NMR Methods in Study of Two Models of Autism

(2018) Elzbieta Zieminska et al.   Frontiers in Molecular Neuroscience

Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia

(2017) Jesper F. Havelund et al.   JOURNAL OF NEUROCHEMISTRY

metabolic profiling of Parkinson's disease and mild cognitive impairment

(2017) Florence Burté et al.   MOVEMENT DISORDERS

Metabolomic biomarkers as strong correlates of Parkinson disease progression

(2017) Peter A. LeWitt et al.   NEUROLOGY

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease

(2017) Shinji Saiki et al.   Scientific Reports

Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis

(2016) Medi Kori et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Proton MR Spectroscopy for Diagnosis and Evaluation of Treatment Efficacy in Parkinson Disease

(2016) Leslie Mazuel et al.   RADIOLOGY

Acetyl Coenzyme A: A Central Metabolite and Second Messenger

(2015) Federico Pietrocola et al.   Cell Metabolism

Identification of novel biomarkers for Parkinson's disease by metabolomic technologies

(2015) Taku Hatano et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson’s disease

(2015) Hemi Luan et al.   Scientific Reports

Both Creatine and Its Product Phosphocreatine Reduce Oxidative Stress and Afford Neuroprotection in an In Vitro Parkinson’s Model

(2014) Mauricio Peña Cunha et al.   ASN Neuro

NMR-based Metabonomics of Cerebrospinal Fluid Applied to Amyotrophic Lateral Sclerosis

(2013) Beata Toczylowska et al.   Biocybernetics and Biomedical Engineering

Usefulness of Proton and Phosphorus MR Spectroscopic Imaging for Early Diagnosis of Parkinson's Disease

(2013) Nora Weiduschat et al.   JOURNAL OF NEUROIMAGING

Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson’s Disease: a Pilot Study

(2013) James R. Roede et al.   PLoS One

Whole-Brain Proton MR Spectroscopic Imaging in Parkinson's Disease

(2012) Bonnie E. Levin et al.   JOURNAL OF NEUROIMAGING

Metabolic Changes Detected by Ex Vivo High Resolution 1H NMR Spectroscopy in the Striatum of 6-OHDA-Induced Parkinson’s Rat

(2012) Hong-Chang Gao et al.   MOLECULAR NEUROBIOLOGY

Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment

(2012) Kun Nie et al.   PARKINSONISM & RELATED DISORDERS

cGMP level in idiopathic Parkinson’s disease patients with and without cardiovascular disease – A pilot study

(2011) Bogdan Brodacki et al.   PARKINSONISM & RELATED DISORDERS

Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury

(2010) Emilie Cornille et al.   BMC NEUROSCIENCE

Energy substrate availability as a determinant of neuronal resting potential, GABA signaling and spontaneous network activity in the neonatal cortexin vitro

(2009) Carl D. Holmgren et al.   JOURNAL OF NEUROCHEMISTRY

K-OPLS package: Kernel-based orthogonal projections to latent structures for prediction and interpretation in feature space

(2008) Max Bylesjö et al.   BMC BIOINFORMATICS

Parkinson's disease: clinical features and diagnosis

(2008) J Jankovic   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Reduced brain glutamate in patients with Parkinson's disease

(2007) H. Randall Griffith et al.   NMR IN BIOMEDICINE